Shanghai Heartcare Medical Technology Corp. Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

China Isotope & Radiation Corp.

PW Medtech Group Ltd.

Modern Dental Group Ltd.

Shanghai INT Medical Instruments Co., Ltd.

Essex Bio-Technology Ltd.

Beijing Chunlizhengda Medical Instruments Co., Ltd.

Zylox-Tonbridge Medical Technology Co., Ltd.

Sisram Medical Ltd.

Shanghai Conant Optical Co., Ltd.

Shanghai Heartcare Medical Technology Corp. Ltd.

Venus Medtech (Hangzhou), Inc.

Why is Shanghai Heartcare Medical Technology Corp. Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

Poor long term growth as Operating profit has grown by an annual rate 46.93% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -51.08

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 66.93%, its profits have risen by 81.5%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Heartcare Medical Technology Corp. Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shanghai Heartcare Medical Technology Corp. Ltd.

66.93%

2.98

62.14%

Hang Seng Hong Kong

8.25%

0.41

19.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

21.89%

EBIT Growth (5y)

46.93%

EBIT to Interest (avg)

-51.08

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.67

Sales to Capital Employed (avg)

0.20

Tax Ratio

13.58%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.57

EV to EBIT

-10.52

EV to EBITDA

-11.21

EV to Capital Employed

2.75

EV to Sales

28.23

PEG Ratio

Dividend Yield

ROCE (Latest)

-26.16%

ROE (Latest)

-8.40%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company

ROCE(HY)

Highest at 3.84%

NET SALES(Q)

Highest at HKD 199.28 MM

RAW MATERIAL COST(Y)

Fallen by -0.27% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 0.91 times

OPERATING PROFIT(Q)

Highest at HKD 55.31 MM

OPERATING PROFIT MARGIN(Q)

Highest at 27.75 %

PRE-TAX PROFIT(Q)

Highest at HKD 32.21 MM

NET PROFIT(Q)

Highest at HKD 34.28 MM

EPS(Q)

Highest at HKD 1.42

-3What is not working for the Company

INTEREST(HY)

At HKD 1.22 MM has Grown at 26.04%

DEBT-EQUITY RATIO (HY)

Highest at -60.55 %

Here's what is working for Shanghai Heartcare Medical Technology Corp. Ltd.

Pre-Tax Profit

At HKD 32.21 MM has Grown at 713.83%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Net Profit

At HKD 34.28 MM has Grown at 567.74%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (HKD MM)

Net Sales

Highest at HKD 199.28 MM and Grown

In each period in the last five periods

MOJO Watch

Near term sales trend is very positive

Net Sales (HKD MM)

Net Sales

At HKD 199.28 MM has Grown at 43.13%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Operating Profit

Highest at HKD 55.31 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (HKD MM)

Operating Profit Margin

Highest at 27.75 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at HKD 32.21 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit

Highest at HKD 34.28 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS

Highest at HKD 1.42

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Inventory Turnover Ratio

Highest at 0.91 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -0.27% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai Heartcare Medical Technology Corp. Ltd.

Interest

At HKD 1.22 MM has Grown at 26.04%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Debt-Equity Ratio

Highest at -60.55 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio